Tetra Bio-Pharma Inc.
TBPMQ
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -30.94M | -32.87M | -36.29M | -41.56M | -26.32M |
| Total Depreciation and Amortization | 80.20K | 84.60K | 94.10K | 89.40K | 68.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.14M | 21.36M | 22.07M | 21.78M | 3.17M |
| Change in Net Operating Assets | 3.27M | -414.80K | -4.97M | -549.40K | -1.16M |
| Cash from Operations | -6.46M | -11.84M | -19.10M | -20.24M | -24.24M |
| Capital Expenditure | -9.00K | -87.40K | -126.70K | -266.60K | -296.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -535.40K | -569.00K | -1.17M | -1.42M | -2.28M |
| Cash from Investing | -544.40K | -656.40K | -1.29M | -1.69M | -2.57M |
| Total Debt Issued | 0.00 | 0.00 | 1.25M | 3.00M | 3.00M |
| Total Debt Repaid | -1.45M | -1.07M | -1.79M | -2.00M | -2.00M |
| Issuance of Common Stock | 2.63M | 2.66M | 31.66M | 31.45M | 31.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -398.50K | -398.50K | -3.05M | -2.67M | -2.67M |
| Cash from Financing | 617.30K | 932.40K | 22.62M | 23.96M | 23.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.38M | -11.57M | 2.23M | 2.03M | -2.86M |